Congress Creates Dedicated $6m Pancreatic Cancer Research Program

Congress Creates Dedicated $6m Pancreatic Cancer Research Program

For the first time, the pancreatic cancer community has secured its own dedicated research program for $6 million through the Department of Defense (DoD) Congressionally Directed Medical Research Program (CDMRP). This is the first time that pancreatic cancer has had a dedicated funding program at the DoD specifically for innovative, high-impact research to accelerate discoveries of new treatments and early detection strategies. The Pancreatic Cancer Action Network (PanCAN) has worked tirelessly for some years to make this a reality—along with others.

Pancreatic Cancer is Dangerous Business

This year an estimated 56,770 adults (29,940 men and 26830 women) in America will be diagnosed with pancreatic cancer. This represents 3% of all cancers. Incidence rates are 25% higher in African Americans than in whites. It is estimated that 45,750 deaths (23,800 men and 21,950 women) from the disease this year alone. It is the ninth most common cancer in women and the tenth most among men. It represents the fourth leading cause of cancer death in men and women—and accounts for 7% of all deaths, reports CancerNet

Making it Happen

PanCAN, along with thousands of “relentless and passionate advocates,” lobbied their members of Congress to help make this funding happen.  Securing any funding from the federal government isn’t easy, and TrialSite News commends these activists and PanCAN leadership. A bi-partisan effort helped close the deal—we need more of these collective efforts to bring people together.

About PanCAN

Founded in 1999, PanCAN dedicates its mission to the fight against one of the world’s toughest cancers. With a focus on research, clinical initiatives, patient services and advocacy, they harness a nationwide network and grassroots support in a determination driven to improve patient outcomes today and to double survival tomorrow. Their annual financial reports are available for those interested. Founded by Pamela Acosta Marquardt, they are currently led by Julie M. Fleshman, JD, MDA. 

Call to Action: Have you or a loved one been hit with pancreatic cancer?  Do you seek to support an organization working hard to find cures for pancreatic cancer? Consider giving to PanCAN